Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expressionAbdulla Watad, Hannah Rowe, Tobias Russell, Qiao Zhou, Lisa K Anderson, Almas Khan, Robert Dunsmuir, Peter Loughenbury, Vishal Borse, Abhay Rao, Peter A Millner, Nicola Luigi Bragazzi, Howard Amital, Richard Cuhtbert, Miriam WittmannSee the full list of authors
13 May 2020
Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national registerRosemary J Hollick, Kevin Stelfox, Linda E Dean, Joanna Shim, Karen Walker-Bone, Gary J Macfarlane
10 June 2020
Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteriaWalter P Maksymowych, Susanne Juhl Pedersen, Ulrich Weber, Xenofon Baraliakos, Pedro M Machado, Iris Eshed, Manouk de Hooge, Joachim Sieper, Stephanie Wichuk, Martin Rudwaleit, Désirée van der Heijde, Robert B M Landewé, Denis Poddubnyy, Mikkel Ostergaard, Robert G W Lambert
5 May 2020
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reductionRobert BM Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Owen R Davies, Natasha de Peyrecave, Karen Thomas, Lianne Gensler
7 May 2020
Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?Gareth T Jones, Linda E Dean, Ejaz Pathan, Rosemary J Hollick, Gary J Macfarlane
23 April 2020
High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristicsThomas Renson, Anaïs Depicker, Ann-Sophie De Craemer, Liselotte Deroo, Gaëlle Varkas, Manouk de Hooge, Philippe Carron, Lennart Jans, Nele Herregods, Isabelle Dehaene, Griet Vandenberghe, Kristien Roelens, Filip E Van den Bosch, Dirk Elewaut
16 April 2020
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging studyDésirée van der Heijde, Lianne S Gensler, Atul Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, Mary Katherine Farmer, Dominique Baeten, Nadine Goldammer, Jason Coarse, Marga Oortgiesen, Maxime Dougados
6 April 2020
What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohortsAlexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, Floris van Gaalen, Pierre Hoonhout, Anna Molto, Alain Saraux, Roberta Ramonda, Maxime Dougados, Robert Landewé
24 January 2020
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, Joachim Sieper, Xenofon Baraliakos, Filip Van den Bosch, Walter P Maksymowych, Joerg Ermann, Jessica A Walsh, Tetsuya Tomita, Atul Deodhar, Désirée van der Heijde, Xiaoqi Li, Fangyi Zhao, Clinton C BertramSee the full list of authors
4 November 2019
Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS)Gary J Macfarlane, Ovidiu Rotariu, Gareth T Jones, Ejaz Pathan, Linda E Dean
29 October 2019
